Labisan Cold Sore
Product Images NDC 72941-932

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labisan Cold Sore (NDC 72941-932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupuca Pharma Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Insert)

Drug Facts panel for Labisan Cold Sore lists active ingredients zinc oxide 20.00% (cold sore/blister treatment/first aid sun protectant) and phenol 1.40% (cold sore/blister treatment/first aid antiseptic). It includes uses, warnings, directions for application, inactive ingredients, storage information, and contact details for questions or comments. It emphasizes external use only, avoiding eyes, consulting a physician if needed, and keeping out of reach of children.*

FDA Label Image

Package Back (Lupuca Packaging Back)

Drug Facts panel for Labisan Cold Sore by Lupuca Pharma GmbH. It lists Zinc Oxide 20.00% as the active ingredient and describes its purpose as a cold sore/fever blister treatment and first aid skin protectant. The panel details uses, warnings, directions including application instructions, other product information, and contact details for questions or comments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.